Archer Biosciences, Inc – Product Pipeline Review – Q1 2011

Date: April 1, 2011
Pages: 29
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AAC8FCC55D9EN
Leaflet:

Download PDF Leaflet

Archer Biosciences, Inc – Product Pipeline Review – Q1 2011
Archer Biosciences, Inc - Product Pipeline Review - Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Archer Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Archer Pharmaceuticals, Inc.
  • Brief company overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Archer Pharmaceuticals, Inc. human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Archer Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Archer Pharmaceuticals, Inc.’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy
  • Evaluate Archer Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Archer Pharmaceuticals, Inc. in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Archer Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Archer Pharmaceuticals, Inc..
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Archer Pharmaceuticals, Inc. and identify potential opportunities in those areas.
Archer Biosciences, Inc Snapshot
Archer Biosciences, Inc Overview
Key Information
Key Facts
Archer Biosciences, Inc – Research and Development Overview
Key Therapeutic Areas
Archer Biosciences, Inc – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Archer Biosciences, Inc – Pipeline Products Glance
Archer Biosciences, Inc Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Archer Biosciences, Inc–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Archer Biosciences, Inc – Drug Profiles
ARC-100
  Product Description
  Mechanism of Action
  R&D Progress
ARC-100 + Temodar
  Product Description
  Mechanism of Action
  R&D Progress
ARC-100
  Product Description
  Mechanism of Action
  R&D Progress
ARC-100 + Temodar
  Product Description
  Mechanism of Action
  R&D Progress
ARC-200
  Product Description
  Mechanism of Action
  R&D Progress
Archer Biosciences, Inc – Pipeline Analysis
Archer Biosciences, Inc – Pipeline Products by Therapeutic Class
Archer Biosciences, Inc - Pipeline Products By Target
Archer Biosciences, Inc – Pipeline Products by Route of Administration
Archer Biosciences, Inc – Pipeline Products by Molecule Type
Archer Biosciences, Inc – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 29

LIST OF TABLES

Archer Biosciences, Inc – Pipeline by Therapy Area and Indication, 2011
Archer Biosciences, Inc – Pipeline by Stage of Development, 2011
Archer Biosciences, Inc – Monotherapy Products in Pipeline, 2011
Archer Biosciences, Inc – Combination Treatment Modalities in Pipeline, 2011
Archer Biosciences, Inc - Phase II, 2011
Archer Biosciences, Inc - Phase I, 2011
Archer Biosciences, Inc - Pipeline By Therapeutic Class, 2011
Archer Biosciences, Inc - Pipeline By Target, 2011
Archer Biosciences, Inc – Pipeline By Route of Administration, 2011
Archer Biosciences, Inc – Pipeline By Molecule Type, 2011 26

LIST OF FIGURES

Archer Biosciences, Inc – Pipeline by Therapy Area and Indication, 2011 7
Archer Biosciences, Inc – Pipeline by Stage of Development, 2011 8
Archer Biosciences, Inc – Monotherapy Products in Pipeline, 2011 9
Archer Biosciences, Inc – Combination Treatment Modalities in Pipeline, 2011 10
Archer Biosciences, Inc – Pipeline By Therapeutic Class, 2011 23
Archer Biosciences, Inc – Pipeline By Route of Administration, 2011 25

Ask Your Question

Archer Biosciences, Inc – Product Pipeline Review – Q1 2011
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: